Outcomes following surgical resection of trigeminal schwannomas: a systematic review and meta-analysis.

Neurosurgical review 2023 Vol.46(1) p. 215

Karras CL, Texakalidis P, Thirunavu VM, Nandoliya KR, Khazanchi R, Byrne K, Chandler JP, Magill ST

관련 도메인

Abstract

Although typically benign, trigeminal schwannomas (TS) may require surgical resection when large or symptomatic and can cause significant morbidity. This study aims to summarize the literature and synthesize outcomes following surgical resection of TS. A systematic review was performed according to PRISMA guidelines. Data extracted included patient and tumor characteristics, surgical approaches, and postoperative outcomes. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used for outcome analysis. The initial search yielded 1838 results, of which 26 studies with 974 patients undergoing surgical resection of TS were included. The mean age was 42.9 years and 58.0% were female. The mean tumor diameter was 4.7 cm, with Samii type A, B, C, and D tumors corresponding to 33.4%, 15.8%, 37.2%, and 13.6%, respectively. Over a mean symptom duration of 29 months, patients presented with trigeminal hypesthesia (58.7%), headache (32.8%), trigeminal motor weakness (22.8%), facial pain (21.3%), ataxia (19.4%), diplopia (18.7%), and visual impairment (12.0%). Surgical approaches included supratentorial (61.4%), infratentorial (15.0%), endoscopic (8.6%), combined/staged (5.3%), and anterior (5.7%) or posterior (4.0%) petrosectomy. Postoperative improvement of facial pain (83.9%) was significantly greater than trigeminal motor weakness (33.0%) or hypesthesia (29.4%). The extent of resection (EOR) was reported as gross total (GTR), near total, and subtotal in 77.7%, 7.7%, and 14.6% of cases, respectively. Over a mean follow-up time of 62.6 months, recurrence/progression was noted in 7.4% of patients at a mean time to recurrence of 44.9 months. Patients with GTR had statistically significantly lower odds of recurrence/progression (OR: 0.07; 95% CI: 0.04-0.15) compared to patients with non-GTR. This systematic review and meta-analysis report patient outcomes following surgical resection of TS. EOR was found to be an important predictor of the risk of recurrence. Facial pain was more likely to improve postoperatively than facial hypesthesia. This work reports baseline rates of post-operative complications across studies, establishing benchmarks for neurosurgeons innovating and working to improve surgical outcomes for TS patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 trigeminal scispacy 1
약물 GTR scispacy 1
기법 endoscopic 내시경 dict 1
질환 trigeminal schwannomas C0349582
Trigeminal schwannoma
scispacy 1
질환 tumor C0027651
Neoplasms
scispacy 1
질환 tumors C0027651
Neoplasms
scispacy 1
질환 trigeminal hypesthesia scispacy 1
질환 headache C0018681
Headache
scispacy 1
질환 trigeminal motor weakness scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 ataxia C0004134
Ataxia
scispacy 1
질환 diplopia C0012569
Diplopia
scispacy 1
질환 visual impairment C0042798
Low Vision
scispacy 1
질환 hypesthesia C0020580
Hypesthesia
scispacy 1
질환 benign scispacy 1
질환 D tumors scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1
기타 female scispacy 1
기타 anterior scispacy 1
기타 GTR scispacy 1

MeSH Terms

Humans; Female; Adult; Male; Hypesthesia; Neurilemmoma; Cranial Nerve Neoplasms; Postoperative Complications; Facial Pain

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문